EFFICACY AND SAFETY OF LRP1 RECEPTOR TARGETED BIODEGRADABLE DONEPEZIL HCL NANOPARTICLES FOR ALZHEIMER’S DISEASE
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: AMIRTHALINGAM, Muthukumar (Manipal College of Pharmaceutical Sciences, Pharmaceutics, Manipal,Karnataka, India)
- Co-author(s): Udupa Nayanabhirama
Alzheimer’s disease is a devastating neurodegenerative disease which deteriorates the memory and thinking skills. It affects the normal daily life activities, and the patients highly depend on the caregiver for every basic needs. So, new treatment modalities and effective drugs are required to alleviate the growing geriatric disease.
Donepezil HCl.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.